You are here

  • Home
  • Archive
  • Volume 11, Issue 4
  • Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG

Article metrics

Article menu

This article has a correction. Please see:

Clinical/translational cancer immunotherapy
Original research
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG

 

Online download statistics by month:

Online download statistics by month: April 2023 to September 2025

AbstractFullPdf
Apr 2023726732275
May 2023412417103
Jun 202330130454
Jul 202317117954
Aug 202319519530
Sep 202311912034
Oct 202312312626
Nov 202314414440
Dec 202310610939
Jan 202410010058
Feb 2024808242
Mar 202410410953
Apr 2024788069
May 2024696938
Jun 2024737343
Jul 2024606141
Aug 20244243114
Sep 2024586337
Oct 2024506233
Nov 2024767934
Dec 2024535412
Jan 202510610731
Feb 202520320331
Mar 2025536731
Apr 202511211440
May 2025535839
Jun 2025212415
Jul 2025110
Sep 2025110
Total369037761416